DEPLOYDatabase

Company

Neuralink

Neuralink is a brain-computer interface (BCI) company founded by Elon Musk in 2016, developing implantable brain chips that enable people with paralysis to…

Founded
2016
HQ
Fremont, CA, USA

Funding

$650.0M

Models

1

Overview

Neuralink is a brain-computer interface (BCI) company founded by Elon Musk in 2016, developing implantable brain chips that enable people with paralysis to control computers and devices with their thoughts. The company's N1 Implant is surgically placed by the R1 Robot, and its PRIME Study began first-in-human trials in January 2024 with patient Noland Arbaugh. Neuralink received FDA Breakthrough Device designation, implanted devices in approximately a dozen patients by late 2025, and raised approximately $1.85B in total funding including a $650M Series E at a $9.6B valuation.

Verified record

Verified deployments
None on file
Active incidents
None on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

Founder

Elon Musk

Total funding

approximately $1.85B ($650M Series E at $9.6B valuation)

Products

N1 Implant (brain chip), R1 Robot (surgical robot)

Clinical trial

PRIME Study (NCT06429735, first-in-human)

FDA

Breakthrough Device designation

First patient

Noland Arbaugh (January 2024)

Patients

approximately 12 implanted by late 2025

Data & sources

Web sources

1

1 source backing this record.View all →

Current leadership (1)

Founders (1)

Safety record

No incidents on record for Neuralink.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Neuralink in third-party press

Peer companies